RIO DE JANEIRO, BRAZIL - Access to cannabidiol - a medical marijuana derivative - should become easier for Brazilian consumers from July, with the entrance of a new brand in pharmacies.
Until April, only Prati Donaduzzi pharmaceutical company had been authorized by the Brazilian Health Regulatory Agency (ANVISA) to produce and market cannabidiol within the country, but the company Nunature, founded by American and Brazilian entrepreneurs with an eye on the country's growing market, was also granted authorization.
Since December 2019, ANVISA has authorized companies to apply for authorization to produce and market the marijuana derivative in Brazil. With the only authorization . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here